Tax Appeal Update: Penalty deleted for concealment of income, verification ordered for rectification process The appeal for A.Y. 2005-06 was dismissed, upholding the deletion of the penalty under Section 271(1)(c) as there was no concealment of income. For A.Y. ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tax Appeal Update: Penalty deleted for concealment of income, verification ordered for rectification process
The appeal for A.Y. 2005-06 was dismissed, upholding the deletion of the penalty under Section 271(1)(c) as there was no concealment of income. For A.Y. 2009-10, the matter was remanded back to the A.O to verify the rectification process. The appeals for A.Y. 2011-12 and 2012-13 were decided in favor of the assessee, allowing the entire sales promotion expenses as the CBDT Circular and MCI Regulations did not apply retrospectively to pharmaceutical companies.
Issues Involved: 1. Validity of the penalty imposed under Section 271(1)(c) of the Income Tax Act, 1961. 2. Disallowance of sales promotion expenses under Section 37(1) of the Income Tax Act, 1961. 3. Applicability of CBDT Circular No. 5/2012 and MCI Regulations to pharmaceutical companies.
Issue-wise Detailed Analysis:
1. Validity of the Penalty Imposed under Section 271(1)(c) of the Income Tax Act, 1961 The revenue appealed against the CIT(A)’s order which set aside the penalty imposed by the A.O under Section 271(1)(c) for A.Y. 2005-06. The A.O had imposed a penalty on the grounds of: - Wrong claim of deduction under Section 80IB. - Wrong claim of computer software expenses as revenue expenditure. - Wrong claim of expenditure on gift articles for non-business purposes.
The CIT(A) deleted the penalty, stating there was no concealment of income or furnishing of inaccurate particulars of income by the assessee. The CIT(A) observed that the assessee had disclosed all relevant facts and details at every stage of the proceedings and that the claims were subject to genuine debate and had previously been decided in favor of the assessee by the Tribunal. The Tribunal upheld the CIT(A)’s decision, noting that mere disallowance of claims does not justify the imposition of penalty under Section 271(1)(c).
2. Disallowance of Sales Promotion Expenses under Section 37(1) of the Income Tax Act, 1961 For A.Y. 2009-10, the A.O had disallowed 10% of the sales promotion expenses, which was later corrected to Rs. 99,91,996 under Section 154. The CIT(A) upheld the rectification but noted that the merits of the disallowance could not be contested in an appeal against a rectification order. The Tribunal agreed with the CIT(A) but remanded the matter back to the A.O to verify if the rectification was done without giving the assessee a reasonable opportunity of being heard.
For A.Y. 2011-12 and 2012-13, the A.O disallowed the entire sales promotion expenses based on the MCI regulations and CBDT Circular No. 5/2012, which prohibits giving "freebies" to doctors. The CIT(A) partly allowed the expenses, disallowing only those exceeding Rs. 750 per article. The Tribunal, after detailed deliberation, held that the MCI regulations apply only to medical practitioners and not to pharmaceutical companies. It concluded that the CBDT Circular No. 5/2012, which extended the MCI regulations to pharmaceutical companies, could not be applied retrospectively and was beyond the CBDT's jurisdiction. Consequently, the Tribunal allowed the entire sales promotion expenses for both years.
3. Applicability of CBDT Circular No. 5/2012 and MCI Regulations to Pharmaceutical Companies The Tribunal examined whether the MCI regulations and the CBDT Circular No. 5/2012 applied to pharmaceutical companies. It found that: - The MCI regulations govern the conduct of medical practitioners and do not apply to pharmaceutical companies. - The CBDT Circular No. 5/2012, which extended the MCI regulations to pharmaceutical companies, was issued without any enabling provision under the Income Tax Act or the Indian Medical Council Regulations. - The Tribunal held that the CBDT could not impose new burdens or liabilities on pharmaceutical companies retrospectively.
The Tribunal concluded that the sales promotion expenses incurred by the assessee were legitimate business expenditures and not prohibited by law, thus allowing the deductions claimed by the assessee for both A.Y. 2011-12 and 2012-13.
Summary of Judgments: - The appeal by the revenue for A.Y. 2005-06 was dismissed, upholding the deletion of the penalty under Section 271(1)(c). - The appeal by the assessee for A.Y. 2009-10 was allowed for statistical purposes, remanding the matter back to the A.O. - The cross appeals for A.Y. 2011-12 and 2012-13 were decided in favor of the assessee, allowing the entire sales promotion expenses and dismissing the revenue's appeals.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.